The Prostate Cancer Dilemma: Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy - Couverture souple
Synopsis
Part One: Diagnosis
Chapter 1: History of Prostate Specific Antigen, from Detection to Over Diagnosis
Brandon J. Manley and Gerald L. Andriole
Chapter 2: Pathology of Prostate Cancer: What Has Changed in the Last 30 Years
M. Scott Lucia
Chapter 3: Clinical Risk Prediction Tools for Prostate Cancer: TNM to CAPRA - Should Risk be Re-Defined?
Michael S. Leapman and Matthew R. Cooperberg
Chapter 4: TRUS Biopsy: Is There Still a Role?
Michael S. Leapman and Katsuto Shinohara
Chapter 5: Transperineal Biopsy Technique
Nelson N. Stone, Vasileios M. Skouteris, and E. David Crawford
Chapter 6: 3D Biopsy: A New Method to Diagnose Prostate Cancer
Kevin Krughoff, Nelson N. Stone, Jesse Elliott, Craig Baer, Paul Arangua, E. David Crawford
Chapter 7: Elastography - Can It Improve Prostate Biopsy Results?
Vassilios M. Skouteris, Spyros D. Yarmenitis, and Georgios P. Zacharopoulos
Chapter 8: Multiparametric MRI of the Prostate as a Tool for Prostate Cancer Detection, Localization, and Risk Assessment
Marc A. Bjurlin, Neil Mendhiratta, and Samir S. Taneja
Chapter 9: Genomic Markers
Neal D. Shore and Karen Ventii
Part Two: Treatment
Chapter 10: Current Status of Clinical Trials in Active Surveillance
Laurence Klotz
Chapter 11: Focused Targeted Therapy in Prostate Cancer
Kevin Krughoff and Al Barqawi
Chapter 12: Technologies and Methods in Primary Ablation with Focal Therapy
Gary Onik
Chapter 13: Multiparametric MRI (mpMRI) - Guided Focal Therapy
Michele Fascelli, Amichai Kilchevsky, Arvin K. George, Peter A. Pinto
Conclusions
Nelson N. Stone and E. David Crawford
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
